JAGSNPHARM Jagsonpal Pharmaceuticals Ltd Earnings Reports Announcement 2024 - Q1FY25 Results Announcement Jagsonpal Pharmaceuticals announces Q1FY25 results with revenues at Rs 61.4 Crores and operating EBITDA at Rs 12.7 Crores, showing growth and margins at 20.6%..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Jagsonpal Pharmaceuticals Ltd